Impact of heart failure hospitalizations on clinical outcomes after mitral transcatheter edge-to-edge repair: Results from the EXPAND study - PubMed (original) (raw)

Multicenter Study

. 2024 Jul;26(7):1495-1503.

doi: 10.1002/ejhf.3250. Epub 2024 May 10.

Wolfgang Rottbauer 1, Ralph Stephan von Bardeleben 2, Carmelo Grasso 3, Philipp Lurz 2, Paul Mahoney 4, Matthew Price 5, Mathew Williams 6, Paolo Denti 7, Rodrigo Estevez-Loureiro 8, Saibal Kar 9, Francesco Maisano 7

Affiliations

Free article

Multicenter Study

Impact of heart failure hospitalizations on clinical outcomes after mitral transcatheter edge-to-edge repair: Results from the EXPAND study

Mirjam Kessler et al. Eur J Heart Fail. 2024 Jul.

Free article

Abstract

Aim: This analysis aimed to compare the clinical outcomes associated with heart failure (HF) readmissions and to identify associations with HF hospitalizations (HFH) in patients treated with the MitraClip™ NTR/XTR System in the EXPAND study.

Methods and results: The global, real-world EXPAND study enrolled 1041 patients with primary or secondary mitral regurgitation (MR) treated with the MitraClip NTR/XTR System. Echocardiograms were analysed by an independent echocardiographic core laboratory. The study population was stratified into HFH and No-HFH groups based on the occurrence of HFH 1 year post-index procedure. Clinical outcomes including MR severity, New York Heart Association (NYHA) functional class, Kansas City Cardiomyopathy Questionnaire (KCCQ) score, and all-cause mortality were compared (HFH: n = 181; No-HFH: n = 860). Both groups achieved consistent 1-year MR reduction to ≤1+ (HFH vs. No-HFH: 87.3% vs. 89.5%, p = 0.6) and significant 1-year improvement in KCCQ scores (+16.5 vs. +22.3, p = 0.09) and NYHA functional class. However, more patients in the No-HFH group had 1-year NYHA class ≤II (HFH vs. No-HFH: 67.9% vs. 81.9%, p < 0.01). All-cause mortality at 1 year was 36.8% in the HFH group versus 10.4% in the No-HFH group (p < 0.001). The HFH rate decreased by 63% at 1 year post-M-TEER versus 1 year pre-treatment (relative risk 0.4, p < 0.001). Independent HFH associations were MR ≥2+ at discharge, HFH 1 year prior to treatment, baseline NYHA class ≥III, baseline tricuspid regurgitation ≥2+, and baseline left ventricular ejection fraction ≤40%.

Conclusions: This study reports the impact of HFH on clinical outcomes post-treatment in the EXPAND study. Results demonstrate that the occurrence of HFH was associated with worse 1-year survival, and treatment with the MitraClip system substantially reduced HFH and improved patient symptoms and quality of life.

Keywords: Heart failure hospitalization; Mitral regurgitation; Mitral valve repair; Transcatheter edge‐to‐edge repair.

© 2024 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

PubMed Disclaimer

References

    1. Malik A, Gill GS, Lodhi FK, Tummala LS, Singh SN, Morgan CJ, et al. Prior heart failure hospitalization and outcomes in patients with heart failure with preserved and reduced ejection fraction. Am J Med 2020;133:84–94. https://doi.org/10.1016/j.amjmed.2019.06.040
    1. Arundel C, Lam PH, Khosla R, Blackman MR, Fonarow GC, Morgan C, et al. Association of 30‐day all‐cause readmission with long‐term outcomes in hospitalized older Medicare beneficiaries with heart failure. Am J Med 2016;129:1178–1184. https://doi.org/10.1016/j.amjmed.2016.06.018
    1. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 2007;154:260–266. https://doi.org/10.1016/j.ahj.2007.01.041
    1. Fudim M, O'Connor CM, Dunning A, Ambrosy AP, Armstrong PW, Coles A, et al. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: Insights from ASCEND‐HF. Eur J Heart Fail 2018;20:304–314. https://doi.org/10.1002/ejhf.1020
    1. Psotka MA, Fonarow GC, Allen LA, Joynt Maddox KE, Fiuzat M, Heidenreich P, et al. The Hospital Readmissions Reduction Program: Nationwide perspectives and recommendations: A JACC: Heart Failure position paper. JACC Heart Fail 2020;8:1–11. https://doi.org/10.1016/j.jchf.2019.07.012

Publication types

MeSH terms

LinkOut - more resources